We are live on ! Find out more
EU

Emory University Portfolio holdings

AUM $160M
1-Year Est. Return 8.57%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+8.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$153M
AUM Growth
+$2.13M
Cap. Flow
+$1.9M
Cap. Flow %
1.24%
Top 10 Hldgs %
48.62%
Holding
52
New
6
Increased
15
Reduced
19
Closed
6

Top Buys

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$2.97M
2
SLDB icon
Solid Biosciences
SLDB
+$2.92M
3
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$2.86M
4
TVTX icon
Travere Therapeutics
TVTX
+$2.79M
5
DOVA
Dova Pharmaceuticals, Inc. Common Stock
DOVA
+$2.77M

Top Sells

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$2.89M
2
CORI
Corium International, Inc.
CORI
+$2.2M
3
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$2.2M
4
KALA icon
KALA BIO
KALA
+$2.12M
5
BPMC
Blueprint Medicines
BPMC
+$2.1M

Sector Composition

Rank Sector Weight
1 Healthcare 49.75%
2 Financials 31.55%
3 Consumer Discretionary 7%
4 Industrials 2.82%
5 Communication Services 1.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DOVA
26
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$2.44M 1.59%
+116,146
New +$2.77M
ALNY icon
27
Alnylam Pharmaceuticals
ALNY
$30.4B
$2.42M 1.59%
27,684
+1,428
+5% +$144K
LJPC
28
DELISTED
La Jolla Pharmaceutical Company
LJPC
$2.37M 1.55%
117,476
+34,313
+41% +$897K
KKR icon
29
KKR & Co
KKR
$103B
$2.3M 1.51%
84,486
-15,073
-15% -$403K
HRTX icon
30
Heron Therapeutics
HRTX
$63.5M
$2.21M 1.45%
69,840
-14,635
-17% -$545K
TFCF
31
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$2.21M 1.45%
48,194
-9,816
-17% -$445K
C icon
32
Citigroup
C
$233B
$2.2M 1.44%
30,606
+795
+3% +$56.2K
TRN icon
33
Trinity Industries
TRN
$2.34B
$2.16M 1.41%
81,809
-3,423
-4% -$89.8K
AWI icon
34
Armstrong World Industries
AWI
$7.68B
$2.16M 1.41%
30,992
-6,077
-16% -$419K
BFH icon
35
Bread Financial
BFH
$4.51B
$2.12M 1.39%
11,256
-1,775
-14% -$335K
IOVA icon
36
Iovance Biotherapeutics
IOVA
$2.95B
$2.09M 1.37%
185,915
+10,318
+6% +$146K
MS icon
37
Morgan Stanley
MS
$343B
$2.08M 1.36%
44,731
+5,199
+13% +$254K
SLM icon
38
SLM Corp
SLM
$5.22B
$2.06M 1.35%
184,813
-2,941
-2% -$34.1K
GBT
39
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.05M 1.34%
53,951
-366
-0.7% -$16.2K
CBRE icon
40
CBRE Group
CBRE
$44B
$2.01M 1.32%
45,617
-551
-1% -$26.3K
STX icon
41
Seagate
STX
$209B
$1.87M 1.23%
39,579
+2,074
+6% +$111K
TGTX icon
42
TG Therapeutics
TGTX
$7.34B
$1.3M 0.85%
231,989
+36,526
+19% +$417K
SMC
43
Summit Midstream
SMC
$480M
$1.25M 0.82%
5,837
– –
COCP icon
44
Cocrystal Pharma
COCP
$15.2M
$382K 0.25%
12,743
– –
AMZN icon
45
Amazon
AMZN
$2.86T
$316K 0.21%
3,160
– –
SPY icon
46
State Street SPDR S&P 500 ETF Trust
SPY
$815B
$254K 0.17%
872
– –
BPMC
47
DELISTED
Blueprint Medicines
BPMC
– –
-33,101
Closed -$2.1M
KALA icon
48
KALA BIO
KALA
$17.9M
– –
-62
Closed -$2.12M
NGNE icon
49
Neurogene
NGNE
$713M
– –
-10,460
Closed -$554K
ABMD
50
DELISTED
Abiomed Inc
ABMD
– –
-7,065
Closed -$2.89M
1
2
3

Similar funds

SGCM
Sanchez Gaunt Capital Management Reno, Nevada $160M AUM
LCA
Legend Capital Advisors New York $160M AUM
SMF
Sterling Manor Financial Saratoga Springs, New York $160M AUM 13.84% 1-Year Est. Return
PCC
Perry Creek Capital New York $160M AUM 3.05% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
RCWM
Royal Capital Wealth Management Carmel, Indiana $161M AUM 18.42% 1-Year Est. Return
BFAG
Blackston Financial Advisory Group The Villages, Florida $160M AUM 16.38% 1-Year Est. Return
SLG
Sanchez Levi Garrett $159M AUM

Emory University's Q3 2018 Portfolio in Review

As of Q3 2018, Emory University held 52 positions worth $153M, up 1.4% from $151M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Emory University's Q3 2018 filing shows 6 new, 15 increased, 19 reduced and 6 closed positions. Its largest new stake was Immunomedics Inc: 125,252 shares worth $2.61M. The largest sale was Abiomed Inc, an estimated $2.89M.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 48% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Emory University's largest Q3 2018 buy was Immunomedics Inc: 125,252 shares worth $2.61M.
  • Emory University added most to La Jolla Pharmaceutical Company in Q3 2018, an estimated $897K increase.
  • Emory University's biggest Q3 2018 reduction was Genomic Health, Inc., cutting an estimated $1.33M.
  • Emory University fully exited Abiomed Inc in Q3 2018, selling an estimated $2.89M.
  • Emory University's ten largest holdings make up 49% of its $153M portfolio in Q3 2018.
  • Emory University opened 6 new positions and closed 6 in Q3 2018.
  • Emory University's portfolio value rose 1.4% quarter-over-quarter to $153M.

Based on Emory University's 13F filing for Q3 2018, filed 14 Nov 2018.